These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 37575228)

  • 1. Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy.
    Yang R; Chen L; Wang Y; Zhang L; Zheng X; Yang Y; Zhu Y
    Front Immunol; 2023; 14():1237361. PubMed ID: 37575228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment triggered biodegradation of inorganic nanoparticles for enhanced tumor theranostics.
    Yang W; Yang S; Jiang L; Zhou Y; Yang C; Deng C
    RSC Adv; 2020 Jul; 10(45):26742-26751. PubMed ID: 35515788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles mediated tumor microenvironment modulation: current advances and applications.
    Raju GSR; Pavitra E; Varaprasad GL; Bandaru SS; Nagaraju GP; Farran B; Huh YS; Han YK
    J Nanobiotechnology; 2022 Jun; 20(1):274. PubMed ID: 35701781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile Synthesis of Fe
    Qi C; Wang W; Wang P; Cheng H; Wang X; Gong B; Xie A; Shen Y
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
    Lv W; Cao M; Liu J; Hei Y; Bai J
    Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment.
    Zhang N; Zhou J; Li S; Cai W; Ru B; Hu J; Liu W; Liu X; Tong X; Zheng X
    Mol Pharm; 2024 Feb; 21(2):410-426. PubMed ID: 38170627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment.
    Sia CS; Lim HP; Tey BT; Goh BH; Low LE
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188779. PubMed ID: 35977690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional MnO
    Yang G; Ji J; Liu Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1720. PubMed ID: 33908171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy.
    Peng S; Xiao F; Chen M; Gao H
    Adv Sci (Weinh); 2022 Jan; 9(1):e2103836. PubMed ID: 34796689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cu
    Xu H; Su Z; Zhang H; Zhang Y; Bao Y; Zhang H; Wu X; Yan R; Wang Z; Jin Y
    Int J Pharm; 2023 Jun; 640():123002. PubMed ID: 37254284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Tumor Microenvironment by Metal Peroxide Nanoparticles in Cancer Therapy.
    Mbugua SN
    Bioinorg Chem Appl; 2022; 2022():5041399. PubMed ID: 36568636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy.
    Zhou W; Jia Y; Liu Y; Chen Y; Zhao P
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanozyme-Based Enhanced Cancer Immunotherapy.
    Phan NM; Nguyen TL; Kim J
    Tissue Eng Regen Med; 2022 Apr; 19(2):237-252. PubMed ID: 35099759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy.
    Zhang J; Lin Y; Lin Z; Wei Q; Qian J; Ruan R; Jiang X; Hou L; Song J; Ding J; Yang H
    Adv Sci (Weinh); 2022 Feb; 9(5):e2103444. PubMed ID: 34927373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smart Nanoparticle-Based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy.
    Cheng R; Santos HA
    Adv Healthc Mater; 2023 Mar; 12(8):e2202063. PubMed ID: 36479842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Microenvironment Responsive RNA Drug Delivery Systems: Intelligent Platforms for Sophisticated Release.
    Wang G; Zhang M; Lai W; Gao Y; Liao S; Ning Q; Tang S
    Mol Pharm; 2024 Sep; 21(9):4217-4237. PubMed ID: 39056442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy.
    Li Q; Liu X; Yan C; Zhao B; Zhao Y; Yang L; Shi M; Yu H; Li X; Luo K
    Small; 2023 Jun; 19(23):e2206211. PubMed ID: 36890780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multistage-responsive nanovehicle to improve tumor penetration for dual-modality imaging-guided photodynamic-immunotherapy.
    Feng Y; Xie X; Zhang H; Su Q; Yang G; Wei X; Li N; Li T; Qin X; Li S; Wu C; Zheng C; Zhu J; You F; Wang G; Yang H; Liu Y
    Biomaterials; 2021 Aug; 275():120990. PubMed ID: 34186239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Microenvironment-Activated Reactive Oxygen Species Amplifier for Enzymatic Cascade Cancer Starvation/Chemodynamic /Immunotherapy.
    Wang M; Chang M; Li C; Chen Q; Hou Z; Xing B; Lin J
    Adv Mater; 2022 Jan; 34(4):e2106010. PubMed ID: 34699627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.